Last reviewed · How we verify
LB54640
At a glance
| Generic name | LB54640 |
|---|---|
| Sponsor | LG Chem |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity (PHASE2)
- A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity (PHASE2)
- A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |